Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Working Capital Changes (2019 - 2025)

Cyclerion Therapeutics has reported Other Working Capital Changes over the past 7 years, most recently at -$46000.0 for Q3 2025.

  • Quarterly results put Other Working Capital Changes at -$46000.0 for Q3 2025, down 204.55% from a year ago — trailing twelve months through Sep 2025 was -$74000.0 (down 100.0% YoY), and the annual figure for FY2024 was $5000.0, up 103.12%.
  • Other Working Capital Changes for Q3 2025 was -$46000.0 at Cyclerion Therapeutics, down from $6000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for CYCN hit a ceiling of $269000.0 in Q4 2022 and a floor of -$794000.0 in Q4 2021.
  • Median Other Working Capital Changes over the past 5 years was $5000.0 (2022), compared with a mean of -$80058.8.
  • Peak annual rise in Other Working Capital Changes hit 2480.0% in 2023, while the deepest fall reached 2744.44% in 2023.
  • Cyclerion Therapeutics' Other Working Capital Changes stood at -$794000.0 in 2021, then soared by 133.88% to $269000.0 in 2022, then crashed by 130.11% to -$81000.0 in 2023, then skyrocketed by 51.85% to -$39000.0 in 2024, then decreased by 17.95% to -$46000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were -$46000.0 (Q3 2025), $6000.0 (Q2 2025), and $5000.0 (Q1 2025) per Business Quant data.